# The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery

> **NCT03699462** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 106 (actual)

## Conditions studied

- Coronary Artery Occlusive Disease(CAOD)

## Interventions

- **DRUG:** Plasma solution-A injection
- **DRUG:** 5% Albumin

## Key facts

- **NCT ID:** NCT03699462
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-13
- **Primary completion:** 2020-10-17
- **Final completion:** 2020-10-17
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03699462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03699462, "The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03699462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*